Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Morning Overview on MSN
ARPA-H is building clinical AI agents designed for FDA authorization and trials
The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, published a new program on January 13, 2026, with an ambitious target: building the ...
Morning Overview on MSN
Study shows immune cells can be engineered inside the body to fight cancer
Scientists have built functional cancer-fighting immune cells directly inside living animals, skipping the expensive and time-consuming process of extracting a patient’s cells and engineering them in ...
Zurich-based Rivia raises €13M to expand its agentic AI platform for biotech clinical trials, building on a €3M seed in 2024.
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and ...
The Citizens Life Sciences Conference 2026 March 10, 2026 4:00 PM EDTCompany ParticipantsMark Jacobson - Chief ...
HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and ...
Abstract: Decision trees, as a structured representation of medical knowledge, are critical resources for building clinical decision support systems. Their structured decision pathways can be used for ...
Camp4 Therapeutics FY25 GAAP EPS missed expectations, but ended the year with a robust cash position. Check out why CAMP ...
Clinical decision support systems (CDSSs) have been proposed to address these challenges; however, current literature reveals significant heterogeneity and gaps in CDSSs used for hypertension ...
Abstract: Generative Artificial Intelligence (GenAI) holds transformative potential for Clinical Decision Support Systems (CDSS), enabling automated, data-driven insights across diagnostic and ...
Halitosis is an unpleasant condition that causes social restraint. Studies worldwide indicate a high prevalence of moderate halitosis, whereas severe cases are restricted to around 5% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results